ArticleJournal of nanobiotechnology2025
Hierarchical chirality of bone cement drives osteoinduction via integrin dependent signaling to accelerate critical bone defect regeneration.
Article in Journal of nanobiotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The biocompatibility and degradability of calcium phosphate bone cement (CPC) make it a potential therapeutic strategy to critical bone defects repair. However, it fails to create a stable extracellular microenvironment for inducing stem cells osteogenic differentiation, which hinders the wider clinical application. Receiving inspiration from chiral structures in biological organisms, particularly skeleton, we incorporated hierarchical chiral hydroxyapatite (CHA) into CPC to fabricate the microenvironment conducive to bone repair. Interestingly, levorotatory hydroxyapatite (LH) cement significantly enhanced osteogenic differentiation of human bone marrow mesenchymal stem cells (hBMSCs), followed by racemic hydroxyapatite (RH) cement. Whereas dextral hydroxyapatite (DH) and achiral hydroxyapatite (HA) cement didn't display a comparable effect. The differentiated osteoblasts and osteogenic proteins on the LH cement continuously recruited stem cells, facilitating the construction of osteoinductive microenvironment. Regard to the underlying mechanism, LH bone cement tightly bound to integrin α9, thereby facilitating the activation of PI3K/AKT pathway and enhancing the expression of osteogenic transcription factors. Following the implantation of LH bone cement into femur defect of rabbits, it exhibited good biocompatibility, enhanced the vascularization of bone defect region, and accelerated new bone formation effectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.